1/5/23 20:26  | 1/4/23  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | S.dm | -13 | 5.52 | 0 | -2 | -4 | 58 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/2/22 17:20  | 2/1/22  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | M.d | 10 | 4.11 | 0 | 2 | 7 | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/5/22 20:25  | 1/5/22  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | S.d | -15 | 10.61 | 0 | -1 | -4 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/21 16:54  | 3/3/21  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | M.d | 11 | 3.72 | 0 | 3 | 14 | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/16/20 07:00  | 3/13/20  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | M.d | 7 | 3.72 | 0 | 2 | 22 | 11 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/24/20 16:58  | 1/23/20  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | M.d | 4 | 3.72 | 0 | 1 | 13 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/19/19 21:58  | 7/18/19  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | CFO | M.d | 7 | 3.72 | 0 | 2 | 33 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/17/19 17:52  | 1/17/19  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 7 | 3.72 | 0 | 2 | 50 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/7/18 16:07  | 12/6/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.dm | 8 | 2.81 | 0 | 3 | 220 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/7/18 16:07  | 12/6/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -26 | 34.00 | 0 | -1 | -16 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/7/18 18:15  | 11/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 | 60 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/7/18 18:15  | 11/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -31 | 41.38 | 0 | -1 | -27 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/10/18 16:45  | 10/8/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 | 60 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/10/18 16:45  | 10/8/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -33 | 44.52 | 0 | -1 | -27 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/6/18 16:07  | 9/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 8 | 2.81 | 0 | 3 |  | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/6/18 16:07  | 9/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -45 | 59.60 | 0 | -1 | -27 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/6/18 18:18  | 8/6/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/6/18 18:18  | 8/6/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -38 | 50.79 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/5/18 15:21  | 7/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/5/18 15:21  | 7/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -34 | 45.66 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/5/18 14:23  | 6/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/5/18 14:23  | 6/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -29 | 38.77 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/7/18 15:04  | 5/7/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/7/18 15:04  | 5/7/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -34 | 45.00 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/18 16:04  | 4/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/18 16:04  | 4/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -28 | 37.47 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/6/18 16:01  | 3/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/6/18 16:01  | 3/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -20 | 26.55 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/18 11:00  | 2/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/18 11:00  | 2/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -17 | 22.99 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/8/18 09:42  | 1/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | M.d | 0 | 0.3900 | 0 | 1 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/8/18 09:42  | 1/5/18  | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moses Jennifer K. | NC | O | VP of Fi | S.d | -15 | 19.96 | 0 | -1 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |